First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) — Net Asset Quality Index
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) has a Net Asset Quality Index of 88.6% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $290.58 Million minus total liabilities of $33.11 Million yields net assets of $257.46 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read TRAXV total debt and obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued Net Asset Quality Index Over Time (2023–2024)
This chart shows how First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued's Net Asset Quality Index has evolved across 2 annual periods from 2023 to 2024. As of March 2026, the index stands at 88.6%, representing net assets of $257.46 Million against total assets of $290.58 Million USD. For live market cap and overall valuation, see TRAXV stock market capitalisation.
Annual Net Asset Quality Index for First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (2023–2024)
The table below presents the year-by-year Net Asset Quality Index for First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued from 2023 to 2024, covering 2 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check asset allocation strategy of First Tracks Biotherapeutics, Inc. Ordin to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 88.6% | $391.60 Million | $441.89 Million | $50.30 Million | ▼ -3.7 pp |
| 2023 | 92.3% | $409.85 Million | $444.11 Million | $34.26 Million | — |